• Publications
  • Influence
Four anti-protozoal and anti-bacterial compounds from Tapirira guianensis.
Tapirira guianensis is a common tree used in traditional medicine in French Guiana against several infectious diseases (malaria, leishmaniasis, bacteria, etc.). The bioassay-guided purification ofExpand
  • 28
  • 3
Antimicrobial and antileishmanial xanthones from the stem bark of Allanblackia gabonensis (Guttiferae)
The phytochemical study of stem bark of Allanblackia gabonensis has resulted in the isolation and characterisation of one new xanthone derivative, named allanxanthone D, together with 10 knownExpand
  • 13
  • 2
  • PDF
Antimicrobial and antileishmanial xanthones from the stem bark of Allanblackia gabonensis
The phytochemical study of the stem bark of Allanblackia gabonensis has resulted in the isolation and characterization of one new xanthone derivative, named allanxanthone D, together with ten knownExpand
  • 13
  • 1
New clerodane diterpenoids from Laetia procera (Poepp.) Eichler (Flacourtiaceae), with antiplasmodial and antileishmanial activities.
Extracts of Laetia procera (Flacourtiaceae) displayed significant in vitro activity against Plasmodium falciparum. P. falciparum bioassay guided fractionation of a trunk bark extract of this plantExpand
  • 38
Anti-leishmanial lindenane sesquiterpenes from Hedyosmum angustifolium.
The aim of this work is the isolation of anti-leishmanial compounds from the ethyl acetate extracts of the bark of HEDYOSMUM ANGUSTIFOLIUM. We have successfully isolated and characterized fiveExpand
  • 24
  • PDF
Bolivianine, a new sesterpene with an unusual skeleton from Hedyosmum angustifolium, and its isomer, isobolivianine.
Bolivianine, a novel sesterpene with an unprecedented skeleton, has been isolated from the trunk bark of Hedyosmum angustifolium (Chloranthaceae), with isobolivianine, an isomer formed under acidicExpand
  • 28
The living library of The Cotapata National Park in Bolivia: an example of application of Bolivian law on the access to genetic resources
Developing countries with a rich biodiversity want to control the use of this natural patrimony, especially in the research of natural compounds of pharmaceutical interest. Here we present theExpand
  • 3